Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease

P. Portincasa; A. Moschetta; K.J. van Erpecum; M. Vacca; M.P. Petruzzelli; G. Calamita; G. Meyer; G. Palasciano

Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease

Translated title of the contribution: Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease

P. Portincasa, A. Moschetta, K.J. van Erpecum, M. Vacca, M.P. Petruzzelli, G. Calamita, G. Meyer, G. Palasciano

Gastroenterology and Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease
Original language	Undefined/Unknown
Pages (from-to)	177-184
Number of pages	8
Journal	Current Drug Targets. Immune, Endocrine and Metabolic Disorders.
Volume	5
Issue number	2
Publication status	Published - 2005

Cite this

@article{35f8479afc09440aa26873137b2c9e41,

title = "Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease",

author = "P. Portincasa and A. Moschetta and {van Erpecum}, K.J. and M. Vacca and M.P. Petruzzelli and G. Calamita and G. Meyer and G. Palasciano",

year = "2005",

language = "Undefined/Unknown",

volume = "5",

pages = "177--184",

journal = "Current Drug Targets. Immune, Endocrine and Metabolic Disorders.",

issn = "1568-0088",

publisher = "Bentham Science Publishers B.V.",

number = "2",

}

TY - JOUR

T1 - Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease

AU - Portincasa, P.

AU - Moschetta, A.

AU - van Erpecum, K.J.

AU - Vacca, M.

AU - Petruzzelli, M.P.

AU - Calamita, G.

AU - Meyer, G.

AU - Palasciano, G.

PY - 2005

Y1 - 2005

M3 - Article

SN - 1568-0088

VL - 5

SP - 177

EP - 184

JO - Current Drug Targets. Immune, Endocrine and Metabolic Disorders.

JF - Current Drug Targets. Immune, Endocrine and Metabolic Disorders.

IS - 2

ER -